BETTERLIFE PHARMA INC. Deferred Tax Assets, Valuation Allowance
BETTERLIFE PHARMA INC. (BETRF) had Deferred Tax Assets, Valuation Allowance of $2.01 million as of 2018-01-31, per its 10-K filed 2018-05-01.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2018-05-01
- 2015-01-31: Deferred Tax Assets, Valuation Allowance -898.19K CAD; Deferred Tax Assets, Valuation Allowance as first filed -832.01K CAD.
- 2014-01-31: Deferred Tax Assets, Valuation Allowance -635.31K CAD.
- 2013-01-31: Deferred Tax Assets, Valuation Allowance -441.12K CAD.
CAD
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2015-01-31 | -898.19K CAD 10-K · filed 2015-06-17 | -832.01K CAD 10-K · filed 2015-05-15 |
| 2014-01-31 | -635.31K CAD 10-K · filed 2015-06-17 | |
| 2013-01-31 | -441.12K CAD 10-K · filed 2014-05-16 |
USD
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2018-01-31 | $2.01M 10-K · filed 2018-05-01 | |
| 2017-01-31 | $2.35M 10-K · filed 2018-05-01 | -$2.35M 10-K · filed 2017-04-28 |
| 2016-01-31 | -$1.66M 10-K · filed 2017-04-28 | |
| 2015-01-31 | -$705.26K 10-K/A · filed 2016-06-07 |